News

The lawsuit alleges that the companies failed to warn the consumers of Actos regarding the increased risk of bladder cancer associated with pioglitazone, sold under the brand name

The tie up allows Rechon to manufacture and market Zolpimist, an oral spray formulation of zolpidem tartrate, outside North America. As per the terms of the agreement, NovaDel

The drug is used for the reduction of rate of thrombotic cardiovascular (CV) events in patients suffering from acute coronary syndrome (ACS). Brilinta has demonstrated reduction in the

The drug has been approved for use in conjunction with two different hepatitis C drugs, pegylated-interferon and ribavirin. The combined dosage is indicated for the patients who are

Previously, Cosby worked as the president and chief operating officer of Macy’s East, and senior vice president for Property Development of Federated Department Stores. CVS Caremark president and

Affymetrix executive vice president, general counsel and secretary Rick Runkel said they are pleased that the Federal Circuit has affirmed the District Court’s prior rulings that Affymetrix does

The company has posted a net income of $3.35m for the second quarter of 2011, compared to $ 4.14m for the same period in 2010. For the six

The Phase I trial conducted in healthy volunteers and a Phase IIa clinical trial in stable heart failure patients met the safety, tolerability, pharmacokinetics and pharmacodynamic effects of

Onsolis, which will be marketed as Breakyl, is indicated for the management of pain in opioid tolerant, adult patients with cancer. BDSI’s Onsolis is expected to be marketed